New COPD drug BBT002 enters first human safety trials

NCT ID NCT07288554

Recruiting now Symptom relief Sponsor: Bambusa Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This early-stage study tests a new drug called BBT002 in healthy people and those with COPD to see if it is safe and tolerable. Researchers will also look for early signs that it might ease breathing problems. About 68 participants will receive either the drug or a placebo, with doses increased gradually.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Contacts and locations

Locations

Chengdu fifth People's Hospital
RECRUITING

Chengdu, Sichuang, 611130, China
Jiangmen Central Hospital
RECRUITING

Jiangmen, Guangdong, 529000, China
Jiangxi Provincial People's Hospital
RECRUITING

Nanchang, Jiangxi, 330006, China
Qingyuan People's Hospital
RECRUITING

Qingyuan, Guangdong, China
The Affiliated Hospital of Xuzhou Medical University
RECRUITING

Xuzhou, Jiangsu, 221002, China
The First Affiliated Hospital of Guangdong Medical University
RECRUITING

Guangzhou, Guangdong, 510000, China
The First People's Hospital of Xinxiang City
RECRUITING

Xinxiang, Henan, 453000, China
The Second Hospital of Anhui Medical Univesity
RECRUITING

Hefei, Anhui, 230601, China
The third affiliated hosptial of Guangzhou Medical University
RECRUITING

Guangzhou, Guangdong, 020-81292183, China
Yichang Central People's Hospital
RECRUITING

Yichang, Hubei, 443000, China
Zhejiang Provincial People's Hospital
RECRUITING

Hangzhou, Zhejiang, 310014, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.